Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Change in Receivables: 2017-2024

Historic Change in Receivables for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to -$133,000.

  • DiaMedica Therapeutics' Change in Receivables rose 160.46% to $159,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $43,000, marking a year-over-year decrease of 93.86%. This contributed to the annual value of -$133,000 for FY2024, which is 146.34% down from last year.
  • As of FY2024, DiaMedica Therapeutics' Change in Receivables stood at -$133,000, which was down 146.34% from $287,000 recorded in FY2023.
  • DiaMedica Therapeutics' 5-year Change in Receivables high stood at $287,000 for FY2023, and its period low was -$483,000 during FY2020.
  • Over the past 3 years, DiaMedica Therapeutics' median Change in Receivables value was -$48,000 (recorded in 2022), while the average stood at $35,333.
  • As far as peak fluctuations go, DiaMedica Therapeutics' Change in Receivables crashed by 1,223.26% in 2020, and later skyrocketed by 697.92% in 2023.
  • Yearly analysis of 5 years shows DiaMedica Therapeutics' Change in Receivables stood at -$483,000 in 2020, then soared by 56.52% to -$210,000 in 2021, then soared by 77.14% to -$48,000 in 2022, then surged by 697.92% to $287,000 in 2023, then crashed by 146.34% to -$133,000 in 2024.